Radiopharmaceuticals in Nuclear Medicine Market - Global Outlook and Forecast 2022-2028-converted (1)

1. Radiopharmaceuticals in Nuclear Medicine Market - Global Outlook and Forecast 2022-2028 Bharat Book Bureau Provides the Trending Industry Research Report on“Radiopharmaceuticals in Nuclear Medicine Market - Global Outlook and Forecast 2022-2028”under Life Sciences Market Research Report. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports. Executive Summary This report contains market size and forecasts of Radiopharmaceuticals in Nuclear Medicine in global, including the following market information: Global Radiopharmaceuticals in Nuclear Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Radiopharmaceuticals in Nuclear Medicine Market Sales, 2017-2022, 2023-2028, (K MT) Global top five Radiopharmaceuticals in Nuclear Medicine companies in 2021 (%) The global Radiopharmaceuticals in Nuclear Medicine market was valued at 4943.7 million in 2021 and is projected to reach US$ 6857.2 million by 2028, at a CAGR of 4.8% during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Diagnostic Radiopharmaceuticals Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Radiopharmaceuticals in Nuclear Medicine include Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group and Isotec, Inc. (Sigma-Aldrich), etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceuticals in Nuclear Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

2. Total Market by Segment: Global Radiopharmaceuticals in Nuclear Medicine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT) Global Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages, by Type, 2021 (%) Diagnostic Radiopharmaceuticals Therapy Radiopharmaceuticals Enriched Stable Isotopes Global Radiopharmaceuticals in Nuclear Medicine Market, by Application, 2017-2022, 2023- 2028 ($ Millions) & (K MT) Global Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages, by Application, 2021 (%) Diagnostic Application Therapeutic Application Research Pharmaceutical Other Global Radiopharmaceuticals in Nuclear Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT) Global Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa

3. Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Radiopharmaceuticals in Nuclear Medicine revenues in global market, 2017- 2022 (Estimated), ($ millions) Key companies Radiopharmaceuticals in Nuclear Medicine revenues share in global market, 2021 (%) Key companies Radiopharmaceuticals in Nuclear Medicine sales in global market, 2017-2022 (Estimated), (K MT) Key companies Radiopharmaceuticals in Nuclear Medicine sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Bracco Imaging S.P.A. Cambridge Isotope Laboratories, Inc. Cardinal Health, Inc. Covidien, Plc Eczacibasi-Monrol Fujifilm Holdings Corporation GE Healthcare (Subsidiary Of General Electric Company) IBA Group Isotec, Inc. (Sigma-Aldrich) Lantheus Medical Imaging, Inc. Nordion, Inc. Ntp Radioisotopes (Pty), Ltd. Siemens Healthcare (Subsidiary Of Siemens AG) Taiyo Nippon Sanso Corporation Urenco Limited Rotem Industries, Ltd., Inc. Australian Nuclear Association And Technology Organization (ANSTO) Board of Radiation And Isotope Technology (BRIT) Institute of Atomic Energy Polatom Radioisotope Centre Institute of Isotopes Co., Ltd. Institute Of Radioelement (IRE) Browse our full report with Table of Content : https://www.bharatbook.com/report/1330291/radiopharmaceuticals-in-nuclear-medicine- market-global-outlook-and-forecast About Bharat Book Bureau: Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Industry Study, Industry Trends & Analysis, Forecasts Customized

4. Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors. Contact us at: Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Email: poonam@bharatbook.com Website: www.bharatbook.com